SCHEMBL8797326

SCHEMBL8797326

CCS(=O)(=O)c1ccc(N2CC(O)(COc3ccc(Cl)cc3)N=C2c2ccc(Cl)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 8/20 0.41
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA4 P22748 3/20 0.39
CA7 P43166 3/20 0.39
ALDH1A1 P00352 2/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.36
HSD11B1 P28845 1/20 0.35
PTGS1 P23219 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
GAA P10253 1/20 0.34
MAPK1 P28482 1/20 0.34
FLT1 P17948 1/20 0.34
FLT4 P35916 1/20 0.34
KDR P35968 1/20 0.34
MAPT P10636 1/20 0.34
HRH2 P25021 1/20 0.33
HRH1 P35367 1/20 0.33
APOBEC3A P31941 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8801829 0.95 PTGS2 (0.40) PTGS2CA1CA2CA4CA7
SCHEMBL5594142 0.91 PTGS2 (0.52) PTGS2CA1CA2CA4CA7
SCHEMBL5594634 0.91 PTGS2 (0.52) PTGS2CA1CA2CA4CA7
SCHEMBL8798175 0.91 PTGS2 (0.43) PTGS2CA1CA2CA4CA7
SCHEMBL5593908 0.89 PTGS2 (0.52) PTGS2CA1CA2CA4CA7
SCHEMBL5593892 0.89 PTGS2 (0.52) PTGS2CA1CA2CA4CA7
SCHEMBL5594474 0.87 PTGS2 (0.49) PTGS2PTGS1
SCHEMBL5595282 0.87 PTGS2 (0.49) PTGS2PTGS1
SCHEMBL8593853 0.86 PTGS2 (0.45) PTGS2CA1CA2CA4CA7
SCHEMBL8591718 0.86 PTGS2 (0.45) PTGS2CA1CA2CA4CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772600-A1 1,2-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003388-A1 1,2-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed